Literature DB >> 7778025

Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion.

M Kayahara1, T Nagakawa, K Ueno, T Ohta, Y Tsukioka, I Miyazaki.   

Abstract

BACKGROUND: The pattern of tumor spread, vis-à-vis nodal involvement and invasion of the extrapancreatic plexus (Plx), has not been thoroughly described for carcinoma of the pancreatic head area.
METHODS: From 1973 to 1991, 110 patients (49 with carcinoma of the pancreatic head [Ph], 29 with distal bile duct cancer [Bi], and 32 with carcinoma of the papilla of Vater [Pv]) underwent pancreatectomy at Kanazawa University Hospital. Nodal involvement and Plx invasion were precisely evaluated by histopathologic examination.
RESULTS: Thirty-seven (76%) of the 49 patients with Ph, 20 (69%) of the 29 with Bi, and 14 (44%) of the 32 with Pv had nodal involvement. The lymph nodes most commonly involved for Ph were the posterior pancreaticoduodenal lymph nodes (numbers 13a [superior] and 13b [inferior]), the superior mesenteric lymph nodes (number 14), the paraaortic lymph nodes (number 16), and the anterior pancreaticoduodenal lymph nodes (number 17) (13a, 51%; 13b, 47%; 14, 36.7%; 16, 18.4%; 17a, 33%; 17b, 22%). In patients with Bi, lymph nodes around the hepatoduodenal ligament (number 12) and lymph nodes numbers 13a and 14 were most commonly involved (12, 27.6%; 13a, 51.7%; 14, 34.5%). In patients with Pv, lymph node numbers 13b and 14 were most frequently involved (13b, 34.4%; 14, 15.6%). No significant correlation was noted between the tumor size and nodal involvement in these three lesions. Nodal involvement was an important prognostic factor for carcinoma of the pancreatic head area. Plx invasion in these three carcinomas was observed in 61% of patients with Ph, 29% of patients with Bi, and 3% of patients with Pv.
CONCLUSIONS: Nodal involvement and Plx invasion differed significantly among carcinomas of the pancreatic head area. We believe that nodal dissection of at least group number 14 is needed for Ph, Bi, and Pv cancers. In addition, dissection of lymph nodes of number 16 and the Plx around the superior mesenteric artery and celiac axis are needed in Ph cancer. Plx dissection of the first portion of plexus pancreaticus capitalis is needed in Bi cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7778025     DOI: 10.1016/s0039-6060(95)80003-4

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  33 in total

Review 1.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Indications and techniques of extended resection for pancreatic cancer.

Authors:  Akimasa Nakao; Shin Takeda; Soichiro Inoue; Shuji Nomoto; Naohito Kanazumi; Hiroyuki Sugimoto; Tsutomu Fujii
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

3.  Can intestinal innervation be preserved in pancreatoduodenectomy for cancer? Results of an anatomical study.

Authors:  M Nano; H Dal Corso; M Ferronato; M Solej; J P Hornung
Journal:  Surg Radiol Anat       Date:  2003-02-25       Impact factor: 1.246

Review 4.  The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence.

Authors:  Michael B Farnell; Gerard V Aranha; Yuji Nimura; Fabrizio Michelassi
Journal:  J Gastrointest Surg       Date:  2007-12-18       Impact factor: 3.452

5.  Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.

Authors:  M Carpelan-Holmström; S Nordling; E Pukkala; R Sankila; J Lüttges; G Klöppel; C Haglund
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

6.  Does extended pancreaticoduodenectomy increase operative morbidity and mortality vs. standard pancreaticoduodenectomy?

Authors:  C Iacono; L Bortolasi; E Facci; G Falezza; G Prati; G Mangiante; G Serio
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

7.  MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma: correlation with en bloc pathological specimens and diagnostic accuracy.

Authors:  Kentaro Mochizuki; Toshifumi Gabata; Kazuto Kozaka; Yuki Hattori; Yoh Zen; Hirohisa Kitagawa; Masato Kayahara; Tetsuo Ohta; Osamu Matsui
Journal:  Eur Radiol       Date:  2010-02-10       Impact factor: 5.315

8.  Total meso-pancreatoduodenum excision with pancreaticoduodenectomy in lower biliary tract cancer.

Authors:  Yasunari Kawabata; Hikota Hayashi; Noriyoshi Ishikawa; Yoshitsugu Tajima
Journal:  Langenbecks Arch Surg       Date:  2016-04-21       Impact factor: 3.445

9.  En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma.

Authors:  Hirohisa Kitagawa; Hidehiro Tajima; Hisatoshi Nakagawara; Isamu Makino; Tomoharu Miyashita; Masatoshi Shoji; Shinichi Nakanuma; Norihiro Hayashi; Hiroyuki Takamura; Tetsuo Ohta; Hiroshi Ohtake
Journal:  Mol Clin Oncol       Date:  2014-02-27

10.  Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.

Authors:  Satoshi Kondo; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Kazuhiro Tsukada; Masato Nagino; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Masakazu Yamamoto; Masato Kayahara; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Satoshi Hirano; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.